Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-02-28
2006-02-28
Saunders, David (Department: 1644)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S395000, C530S396000, C530S399000, C530S402000, C530S404000, C530S411000
Reexamination Certificate
active
07005415
ABSTRACT:
A heparin-binding protein functionalized by covalently bonding thereto a sugar chain, a method for producing the protein and a pharmaceutical composition containing the protein as an active ingredient, as well as a method for functionalizing a natural protein having no sugar chain by covalently bonding thereto a sugar chain.
REFERENCES:
patent: 4280953 (1981-07-01), Guillemin et al.
patent: 4478746 (1984-10-01), Kim et al.
patent: 5360896 (1994-11-01), Senoo et al.
patent: 5486599 (1996-01-01), Saunders et al.
patent: 2227075 (1990-09-01), None
patent: 8801647 (1988-03-01), None
patent: 9116335 (1991-10-01), None
Jaye et al., Science, vol. 233, pp. 541-545 (Aug. 1986).
Imamura, et al., Science, vol. 249, pp. 1567-1570 (Sep. 1990).
Asada Chie
Asada Masahiro
Imamura Toru
Kojima Tetsuhito
Miyakawa Kazuko
Director-General Agency of Industrial Science and Technology
Saunders David
LandOfFree
Heparin-binding proteins modified with sugar chains, method... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heparin-binding proteins modified with sugar chains, method..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heparin-binding proteins modified with sugar chains, method... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3641056